Eastgate Biotech Corp. (ETBI)
OTCMKTS · Delayed Price · Currency is USD
0.0009
+0.0008 (800.00%)
At close: Jan 22, 2026
Eastgate Biotech Market Cap
Eastgate Biotech has a market cap or net worth of $952.07 thousand as of January 23, 2026. Its market cap has decreased by -77.50% in one year.
Market Cap
952.07K
Enterprise Value
n/a
Revenue
137.64K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 5, 2014, Eastgate Biotech's market cap has decreased from 7.91M to 952.07K, a decrease of -87.96%. That is a compound annual growth rate of -16.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 846.29K | -73.33% |
| Dec 18, 2025 | 3.17M | -33.33% |
| Dec 23, 2024 | 4.76M | 50.00% |
| Dec 30, 2022 | 3.17M | 11.11% |
| Dec 31, 2021 | 2.86M | -32.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CNBX Pharmaceuticals | 217.69K |
| Endonovo Therapeutics | 180.76K |
| Nascent Biotech | 138.27K |
| Scorpius Holdings | 122.29K |
| Synairgen | 110.27K |
| Ocean Biomedical | 92.95K |
| Vincerx Pharma | 65.43K |
| Affymax | 59.59K |